Titan Bio-Tech [TITANBIO] vs Dishman Carbogen [DCAL] Detailed Stock Comparison
Titan Bio-Tech
BSE
Loading...
Dishman Carbogen
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Titan Bio-Tech wins in 9 metrics, Dishman Carbogen wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Titan Bio-Tech | Dishman Carbogen | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.96 | 1,089.32 | Titan Bio-Tech |
| Price-to-Book Ratio | 2.38 | 0.64 | Dishman Carbogen |
| Debt-to-Equity Ratio | 1.82 | 40.97 | Titan Bio-Tech |
| PEG Ratio | N/A | 19.17 | N/A |
| EV/EBITDA | 14.26 | 12.04 | Dishman Carbogen |
| Profit Margin (TTM) | 13.76% | 0.12% | Titan Bio-Tech |
| Operating Margin (TTM) | 10.60% | 10.27% | Titan Bio-Tech |
| EBITDA Margin (TTM) | 10.60% | 10.27% | Titan Bio-Tech |
| Return on Equity | 15.01% | 0.06% | Titan Bio-Tech |
| Return on Assets (TTM) | 8.02% | 1.12% | Titan Bio-Tech |
| Free Cash Flow (TTM) | $106.79M | $1.58B | Dishman Carbogen |
| Dividend Yield | 0.47% | N/A | N/A |
| 1-Year Return | -27.01% | 22.14% | Dishman Carbogen |
| Price-to-Sales Ratio (TTM) | 2.34 | 1.39 | Dishman Carbogen |
| Enterprise Value | $3.63B | $56.48B | Dishman Carbogen |
| EV/Revenue Ratio | 2.32 | 2.08 | Dishman Carbogen |
| Gross Profit Margin (TTM) | 57.31% | 79.63% | Dishman Carbogen |
| Revenue per Share (TTM) | $189 | $176 | Titan Bio-Tech |
| Earnings per Share (Diluted) | $26.08 | $0.22 | Titan Bio-Tech |
| Beta (Stock Volatility) | 0.32 | 0.17 | Dishman Carbogen |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Titan Bio-Tech vs Dishman Carbogen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Titan Bio-Tech | -4.67% | 4.49% | -3.34% | 0.20% | -38.24% | -42.03% |
| Dishman Carbogen | -1.46% | -3.47% | -8.84% | 27.79% | -2.26% | -17.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Titan Bio-Tech | -27.01% | 89.08% | 205.28% | 1,425.34% | 1,669.40% | 1,991.49% |
| Dishman Carbogen | 22.14% | 106.15% | 27.13% | 131.97% | 128.43% | 247.33% |
Performance & Financial Health Analysis: Titan Bio-Tech vs Dishman Carbogen
| Metric | TITANBIO | DCAL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.66B | ₹37.57B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 9,704 | 96,230 |
| 90 Day Avg. Volume | 8,360 | 89,744 |
| Last Close | ₹442.35 | ₹236.15 |
| 52 Week Range | ₹373.65 - ₹1,017.85 | ₹161.21 - ₹307.98 |
| % from 52W High | -56.54% | -23.32% |
| All-Time High | ₹1,017.85 (Oct 21, 2024) | ₹396.40 (Jan 22, 2018) |
| % from All-Time High | -56.54% | -40.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | 0.09% |
| Quarterly Earnings Growth | -0.19% | 0.23% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.00% |
| Operating Margin (TTM) | 0.11% | 0.10% |
| Return on Equity (TTM) | 0.15% | 0.00% |
| Debt to Equity (MRQ) | 1.82 | 40.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹185.75 | ₹372.17 |
| Cash per Share (MRQ) | ₹6.73 | ₹33.98 |
| Operating Cash Flow (TTM) | ₹201.23M | ₹3.75B |
| Levered Free Cash Flow (TTM) | ₹67.81M | ₹666.88M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.47% | N/A |
| Last 12-Month Dividend | ₹2.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Titan Bio-Tech vs Dishman Carbogen
| Metric | TITANBIO | DCAL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.96 | 1,089.32 |
| Forward P/E | N/A | 19.17 |
| PEG Ratio | N/A | 19.17 |
| Price to Sales (TTM) | 2.34 | 1.39 |
| Price to Book (MRQ) | 2.38 | 0.64 |
| Market Capitalization | ||
| Market Capitalization | ₹3.66B | ₹37.57B |
| Enterprise Value | ₹3.63B | ₹56.48B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.32 | 2.08 |
| Enterprise to EBITDA | 14.26 | 12.04 |
| Risk & Other Metrics | ||
| Beta | 0.32 | 0.17 |
| Book Value per Share (MRQ) | ₹185.75 | ₹372.17 |
Financial Statements Comparison: Titan Bio-Tech vs Dishman Carbogen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TITANBIO | DCAL |
|---|---|---|
| Revenue/Sales | ₹351.69M | ₹7.16B |
| Cost of Goods Sold | ₹150.13M | ₹1.46B |
| Gross Profit | ₹201.57M | ₹5.70B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹37.27M | ₹736.00M |
| EBITDA | ₹59.51M | ₹1.61B |
| Pre-Tax Income | ₹50.29M | ₹277.00M |
| Income Tax | ₹12.62M | ₹-153.90M |
| Net Income (Profit) | ₹40.47M | ₹430.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TITANBIO | DCAL |
|---|---|---|
| Cash & Equivalents | ₹51.28M | ₹3.41B |
| Total Current Assets | ₹790.38M | ₹22.00B |
| Total Current Liabilities | ₹177.36M | ₹19.25B |
| Long-Term Debt | ₹4.19M | ₹13.90B |
| Total Shareholders Equity | ₹1.53B | ₹58.32B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹571.62M | ₹29.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TITANBIO | DCAL |
|---|---|---|
| Operating Cash Flow | ₹45.62M | N/A |
| Capital Expenditures | ₹-33.58M | N/A |
| Free Cash Flow | ₹12.24M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TITANBIO | DCAL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 9,704 | 96,230 |
| Average Daily Volume (90 Day) | 8,360 | 89,744 |
| Shares Outstanding | 8.26M | 156.78M |
| Float Shares | 2.64M | 55.08M |
| % Held by Insiders | 0.67% | 0.71% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Titan Bio-Tech vs Dishman Carbogen
| Metric | TITANBIO | DCAL |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.47% | N/A |
| 3-Year Avg Annual Dividend | ₹1.77 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.45% | N/A |
| 3-Year Total Dividends | ₹5.30 | ₹0.00 |
| Ex-Dividend Date | Sep 23, 2024 | N/A |